Concepedia

Abigael T. Gemo

AT

Statistics

Publications

7

Citations

742

H-Index

7

Active since

2007

Affiliations

University of California, Davis(Current)

UC Davis Comprehensive Cancer Center

Five Prime Therapeutics (United States)

Abigael T. Gemo is an author at University of California, Davis specializing in oncology, molecular biology, and molecular oncology.

Publications per year

2007–2015

7

Publications

7

ANCCA/ATAD2 Overexpression Identifies Breast Cancer Patients with Poor Prognosis, Acting to Drive Proliferation and Survival of Triple-Negative Cells through Control of B-Myb and EZH2

Ekaterina Kalashnikova, Alexey S. Revenko, Abigael T. Gemo et al. · Cancer Research · 2010 · 169 citations · Full text

, , +17

Androgen-Induced Coactivator ANCCA Mediates Specific Androgen Receptor Signaling in Prostate Cancer

June X. Zou, Linlang Guo, Alexey S. Revenko et al. · Cancer Research · 2009 · 166 citations · Full text

, , +17

ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERα, is required for coregulator occupancy and chromatin modification

June X. Zou, Alexey S. Revenko, Li B. Li et al. · Proceedings of the National Academy of Sciences · 2007 · 152 citations · Full text

, , +15

Chromatin Loading of E2F-MLL Complex by Cancer-Associated Coregulator ANCCA via Reading a Specific Histone Mark

Alexey S. Revenko, Ekaterina Kalashnikova, Abigael T. Gemo et al. · Molecular and Cellular Biology · 2010 · 134 citations · Full text

, , +17

A phase I, first in human study of FP-1039 (GSK3052230), a novel FGF ligand trap, in patients with advanced solid tumors

Anthony W. Tolcher, Kyriakos P. Papadopoulos, Amita Patnaik et al. · Annals of Oncology · 2015 · 92 citations · Full text

, , +9

1–5 of 7